BridgeBio keeps FDA approval spree rolling, this time with nod for targeted bile duct cancer med

BridgeBio keeps FDA approval spree rolling, this time with nod for targeted bile duct cancer med
fkansteiner
Tue, 06/01/2021 – 11:20